Tawee Tanvetyanon is an Oncology physician affiliated with University of South Florida. OpenAlex indexes 275 publications with 8,149 citations (h-index 42); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Carboplatin, Bevacizumab and Pemetrexed in the First-Line Treatment of Patients With Malignant Pleural Mesothelioma (MPM)
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
38.4%Opioid Agonist14.8%Tramadol Hcl35%Oxycodone Hcl26%Hydromorphone Hcl20%Oxycodone-Acetaminophen20%Part D<11 patientsPhenothiazine10.2%Prochlorperazine Maleate100%Part D≥37 patients+ 3 more classes in this area
Metabolism & gastrointestinal
16.6%Corticosteroid5.5%Prednisone100%Part D≥21 patientsSerotonin-3 Receptor Antagonist4.2%Ondansetron Odt100%Part D≥16 patients+ 2 more classes in this area
Sensory organs
11.9%Corticosteroid11.9%Dexamethasone100%Part D≥35 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
Thomas Casale, MD
University of South Florida
Richard Lockey, MD
University of South Florida
Robert Hauser, MD
University of South Florida
Douglas Reintgen, MD
University of South Florida
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”